1921
Volume 69, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Reports from several sites in South America suggest the presence of isolated cases of chloroquine-resistant malaria. To investigate the possibility of chloroquine-resistant in Peru, we conducted 28-day drug efficacy trials at three sites in the Amazon region and one site on the northern Pacific Coast between 1998 and 2001. A total of 242 patients between the ages of 2 and 60 years were enrolled (177 from the Amazon region and 65 from the northern coast). All subjects received directly observed therapy with chloroquine, 25 mg/kg, over a three-day period. On enrollment, 49% had a documented fever and 96% had a history of fever; their geometric mean parasite density was 5,129 parasites/μL. A total of 212 (88%) of the 242 subjects completed their 28-day follow-up. Four of the 177 patients from the Amazon region had a recurrence of parasitemia on days 21 and 28 after treatment was initiated. Two of these patients had chloroquine-resistant infections, based on polymerase chain reaction-single-stranded conformational polymorphism genotyping and chloroquine-desethylchloroquine blood levels, which were ≥97 ng/mL at the time of the reappearance of parasitemia. None of the subjects studied on the northern Pacific Coast had recurrent parasitemia.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2003.69.548
2003-11-01
2017-11-23
Loading full text...

Full text loading...

/deliver/fulltext/14761645/69/5/0690548.html?itemId=/content/journals/10.4269/ajtmh.2003.69.548&mimeType=html&fmt=ahah

References

  1. Rieckmann KH, Davis DR, Hutton DC, 1989. Plasmodium vivax resistance to chloroquine? Lancet ii : 1183–1184.
  2. Baird JK, Basri H, Purnomo, Bangs MJ, Subianto B, Patchen LC, Hoffman SL, 1991. Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. Am J Trop Med Hyg 44 : 547–552.
  3. Myat-Phone-Kyaw, Myint-Oo, Myint-Lwin, Thaw-Zin, Kyin-Hla-Aye, New-New-Yin, 1993. Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma). Trans R Soc Trop Med Hyg 87 : 687.
  4. Baird JK, Sustriayu Nalim MF, Basri H, Masbar S, Leksana B, Tjitra E, Dewi RM, Khairani M, Wignall FS, 1996. Survey of resistance to chloroquine by Plasmodium vivax in Indonesia. Trans R Soc Trop Med Hyg 90: 409–411.
  5. Garg M, Gopinathan N, Bodhe P, Kshirsagar NA, 1995. Vivax malaria resistant to chloroquine: case reports from Bombay. Trans R Soc Trop Med Hyg 89 : 656–657.
  6. Baird JK, Basri H, Subianto B, Fryauff DJ, McElroy PD, Leksana B, Richie TL, Masbar S, Wignall FS, Hoffman SL, 1995. Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine. J Infect Dis 171 : 1678–1682.
  7. Phillips EJ, Keystone JS, Kain KC, 1996. Failure of combined chloroquine and high dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America. Clin Infect Dis 23 : 1171–1173.
  8. Alecrim MC, Alecrim W, Macedo V, 1999. Plasmodium vivax resistance to chloroquine (R2) and mefloquine (R3) in Brazilian amazon region. Rev Soc Bras Med Trop 32 : 67–68.
  9. Soto J, Toledo J, Gutierrez P, Luzz M, Llinas N, Cedeño N, Dunne M, Berman J, 2001. Plasmodium vivax clinically resistant to chloroquine in Colombia. Am J Trop Med Hyg 65 : 90–93.
  10. Marquiño W, MacArthur JR, Barat LM, Oblitas FE, Arrunátegui M, Garavito G, Chafloque ML, Pardavé B, Gutierrez S, Arróspide N, Carrillo C, Cabezas C, Ruebush TK II, 2003. Efficacy of chloroquine, sulfadoxine-pyrimethamine, and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria on the north coast of Peru. Am J Trop Med Hyg 68 : 120–123.
  11. Roper MH, Torres RS, Goicochea CG, Andersen EM, Guarda JS, Calampa C, Hightower AW, Magill AJ, 2000. The epidemiology of malaria in an epidemic area of the Peruvian Amazon. Am J Trop Med Hyg 62 : 247–256.
  12. Pan American Health Organization, 1998. Evaluation of the Therapeutic Efficacy of Drugs for the Treatment of Uncomplicated Plasmodium falciparum Malaria in the Americas. Washington, DC: OPS/HCP/HCT/113/98.
  13. Bruce-Chwatt LJ, 1986. Chemotherapy of Malaria. Second edition. Geneva: World Health Organization, Monograph Series No. 27, 261.
  14. Patchen LC, Mount DL, Schwartz IK, Churchill FC, 1983. Analysis of filter-paper-absorbed, finger-stick blood samples for chloroquine and its major metabolite using high-performance liquid chromatography with fluorescence detection. J Chromatogr 278 : 81–89.
  15. Craig AA, Kain KC, 1996. Molecular analysis of strains of Plasmodium vivax from paired primary and relapse infections. J Infect Dis 174 : 373–379.
  16. Pan American Health Organization, 2001. Report on the Status of Malaria Programs in the Americas. Washiongton, DC: CD43/ INF/1.
  17. Ministerio de Salud, 2000. Programa de Control de Malaria y Otras Enfermedades Metaxenicas. Lima, Peru.
  18. Ruebush TK II, Zeissig R, Klein RE, Godoy HA, 1992. Community participation in malaria surveillance and treatment. II. Evaluation of the volunteer collaborator network of Guatemala. Am J Trop Med Hyg 46 : 261–271.
  19. Nieto T, Méndez F, Carrasquilla G, 1999. Knowledge, beliefs and practices relevant for malaria control in an endemic urban area of the Colombian Pacific. Soc Sci Med 49 : 601–609.
  20. Kroeger A, Meyer R, Mancheno M, González M, 1996. Health education for community-based malaria control: an intervention study in Ecuador, Colombia, and Nicaragua. Trop Med Int Health 1 : 836–846.
  21. Murphy GS, Basri H, Purnomo, Andersen EM, Bangs MJ, Mount DL, Gorden J, Lal AA, Purwokusumo AR, Harjosuwarno S, Sorensen K, Hoffman SL, 1993. Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet 341 : 96–100.
  22. Baird JK, Leksana B, Masbar S, Fryauff DJ, Sutanihardja MA, Suradi, Wignall FS, Hoffman SL, 1997. Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels. Am J Trop Med Hyg 56 : 621–626.
  23. Coatney GR, Cooper WC, (1948). Recrudescence and relapse in vivax malaria. Proc Fourth Int Cong Trop Med Malaria 1: Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood chloroquine levels. Am J Trop Med Hyg 56 56 : 629–639.
  24. Garavelli PL, Corti E, 1992. Chloroquine resistance in Plasmodium vivax: the first case in Brazil. Trans R Soc Trop Med Hyg 86 : 128.
  25. Cooper RD, Rieckmann KH, 1990. Efficacy of amodiaquine against a chloroquine-resistant strain of Plasmodium vivax. Trans R Soc Trop Med Hyg 84 : 473.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2003.69.548
Loading
/content/journals/10.4269/ajtmh.2003.69.548
Loading

Data & Media loading...

  • Received : 03 Jan 2003
  • Accepted : 14 May 2003

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error